Johnson & Johnson releases results from phase three
single-dose COVID-19 vaccine trials
Johnson & Johnson announced that their new single-dose vaccine showed 85% protection against severe cases of COVID-19. Some advantages of the new vaccine: it’s a single dose and can be stored in a regular refrigerator. Dr.Tara Narula details how this new vaccine works.
